Kyaw Z Thein, Siqing Fu, Filip Janku, Apostolia M Tsimberidou, Sarina A Piha-Paul, Daniel D Karp, Jatin Shah, Denái R Milton, Jing Gong, Selma Sulovic, Lacey McQuinn, Bettzy A Stephen, Rivka R Colen, Brett W Carter, Funda Meric-Bernstam, Aung Naing
{"title":"Selinexor联合卡铂和培美曲塞治疗晚期或转移性实体瘤:一项开放标签、单中心、多组1b期研究的结果","authors":"Kyaw Z Thein, Siqing Fu, Filip Janku, Apostolia M Tsimberidou, Sarina A Piha-Paul, Daniel D Karp, Jatin Shah, Denái R Milton, Jing Gong, Selma Sulovic, Lacey McQuinn, Bettzy A Stephen, Rivka R Colen, Brett W Carter, Funda Meric-Bernstam, Aung Naing","doi":"10.36401/JIPO-21-20","DOIUrl":null,"url":null,"abstract":"with carboplatin and pemetrexed with advanced","PeriodicalId":16081,"journal":{"name":"Journal of Immunotherapy and Precision Oncology","volume":"5 1","pages":"10-12"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/d1/i2590-017X-5-1-10.PMC9138422.pdf","citationCount":"1","resultStr":"{\"title\":\"Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.\",\"authors\":\"Kyaw Z Thein, Siqing Fu, Filip Janku, Apostolia M Tsimberidou, Sarina A Piha-Paul, Daniel D Karp, Jatin Shah, Denái R Milton, Jing Gong, Selma Sulovic, Lacey McQuinn, Bettzy A Stephen, Rivka R Colen, Brett W Carter, Funda Meric-Bernstam, Aung Naing\",\"doi\":\"10.36401/JIPO-21-20\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"with carboplatin and pemetrexed with advanced\",\"PeriodicalId\":16081,\"journal\":{\"name\":\"Journal of Immunotherapy and Precision Oncology\",\"volume\":\"5 1\",\"pages\":\"10-12\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/d1/i2590-017X-5-1-10.PMC9138422.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Immunotherapy and Precision Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36401/JIPO-21-20\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Immunotherapy and Precision Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36401/JIPO-21-20","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
